Promising Omani Startups Programme marks major milestone
MUSCAT: His Highness Sayyid Bilarab bin Haitham al Said, Honorary President of the ‘Programme of Promising Omani Startups’…
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
Milestone Pharma gets FDA approval for first PSVT nasal spray
Milestone (Nasdaq: MIST) announced FDA approval of CARDAMYST (etripamil) nasal spray for conversion…